Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it ...
It is an honor and a privilege to lead such a talented and committed team as Arvinas enters a period where we anticipate ...
Q4 2025 Earnings Call February 24, 2026 10:00 AM ESTCompany ParticipantsChris BrandonMichael Miles - Chairman of the Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results